A pooled analysis investigated the prognostic role of DNA mismatch repair status in patients with stage III colon cancer treated with a standard adjuvant chemotherapy regimen. READ MORE
Several factors should be considered when deciding whether or not hepatectomy is justified for patients with RAS-mutant colorectal liver metastases.
Minimally invasive liver resection (MILR) may offer advantages in the management of colorectal liver metastases.
Perineural invasion in locally advanced gastric cancer is associated with worse outcomes in patients who undergo gastrectomy and adjuvant chemotherapy.
Research in Review
Expression of epidermal growth factor receptor ligands epiregulin and amphiregulin may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy.
Mutations of the BRAF and KRAS genes may be associated with worse outcomes in certain patients with colon cancer, according to a new study.